1Witte MH, Bernas MJ, Martin CP, et al. Lymphangiogenesis and lymphangiodysplasia:from molecular to clinical lymphology[J]. Microsc Res Tech,2001,55(2) : 122.
2Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[J]. Nature Med,2001,7(2) :192.
3Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spead of tumor cells via the lyre phatics[J]. Nature Med, 2001,7(2) : 186.
4Wigle JT, Haryey N, Detmar M, et al. An essential role for prox in the induction of/he lymphatic endothelial cell phenotype[J]. EMBO J,2002,21(7) :1505.
5Witmer AN, Van Blijswijk BC, Dai J, et al. VEGFR-3 in adult angiogenesis[J]. Pathol,2001,195:490.
6Su JL, Yang PC, Shih JY, et al. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells [J]. Cancer Cell, 2006,9 (3) : 209.
7Chang LK, Cardena G, Famebo F, et al. Dose-dependent response of FGF-2 for lymphangiogenesis[J]. Proc Natl Acad Sci USA,2004,101(32):11658.
8Cao R, Bjorndahl MA, Religa P, et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis[J]. Cancer Cell, 2004,6 (4) : 333.
9Morisada T, Oike Y, Yamada Y, et al. Angiopoietin- 1 promotes LYVE-1 positive lymphatic vessel formation[J]. Blood, 2005,105 (12) : 4649.
10Su JL,Shih JY, Yen ML, et al. Cyclooxygenase-2 induces EP1 and HER-2/Neu dependent vascular endothelial growth factor-Cup regulation:a novel mechanism of lymphangiogenesis in lung adenocarcinoma[J]. Cancer Res, 2004,64(2) : 554.
6Sleeman J, Schmid A, Thiele W. Tumor lymphatics [J ]. Semin Cancer Biol,2009,5(29) :243 251.
7Lyden D,Hattori K,Dias s,et al.Impaired recruitment of bone-marrow-derived endothelial and hematopoiefic precumsor cells blocks tumor angiogenesis and growth[J].Nat Med,2001,7(1):1194-1201.
8Gao D,Nolan DJ,Mellick AS,et al.Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis[J].Science,2008,319(5860):195-198.
9Wei J,Blum S,Unger M,et al.Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lungrnetastases after intravenous delivery[J].Cancer Cell,2004,5(5):477-488.
10Purhonen S,Palm J,Rossi D,et al.Bone marrow-derived eirculating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth[J].Proc Natl Acad Sci USA,2008,105(18):6620-6625.
